These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25269700)

  • 1. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.
    Abrams JA; Chak A
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
    Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
    Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
    Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study.
    Li Z; Yang K
    Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
    Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
    Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Barrett's adenocarcinoma.
    Melzer E; Shtoyerman R; Appelman Z; Kashtan H
    Am J Gastroenterol; 2006 Mar; 101(3):677. PubMed ID: 16542304
    [No Abstract]   [Full Text] [Related]  

  • 10. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
    Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.
    Snider EJ; Compres G; Freedberg DE; Khiabanian H; Nobel YR; Stump S; Uhlemann AC; Lightdale CJ; Abrams JA
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1687-1693. PubMed ID: 31466948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
    Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
    Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma.
    Garewal HS; Sampliner R; Liu Y; Trent JM
    Cancer Genet Cytogenet; 1989 Oct; 42(2):281-6. PubMed ID: 2790761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
    Dong J; Maj C; Tsavachidis S; Ostrom QT; Gharahkhani P; Anderson LA; Wu AH; Ye W; Bernstein L; Borisov O; Schröder J; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; May A; Gerges C; Anders M; Venerito M; Schmidt T; Izbicki JR; Hölscher AH; Schumacher B; Vashist Y; Neuhaus H; Rösch T; Knapp M; Krawitz P; Böhmer A; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Corley DA; Gockel I; Fitzgerald RC; ; Cook MB; Whiteman DC; Vaughan TL; Schumacher J; Thrift AP
    Gastroenterology; 2020 Dec; 159(6):2065-2076.e1. PubMed ID: 32918910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Walch A; Mueller J; Höfler H; Werner M
    J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.